Dr Robert Orlowski highlights strategies to prevent infections in patients with multiple myeloma treated with linvoseltamab, emphasizing antiviral prophylaxis and IVIG use.
Robert Orlowski, MD, PhD
Advertisement
Articles by Robert Orlowski, MD, PhD
Robert Orlowski, MD, PhD, Florence Maude Thomas Cancer Research professor and chair, ad interim, Department of Lymphoma & Myeloma at The University of Texas MD Anderson Cancer Center, discusses remaining questions with multiple myeloma treatment.
Advertisement
Latest Updated Articles
Remaining Questions With Multiple Myeloma TreatmentSeptember 14th 2017
Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
Insurance Delays and Travel Strain CAR T Referral in Early Relapsed Myeloma
2
Oncologists Debate Role of On-Body Injector for Transplant-Ineligible Myeloma
3
NCCN Guidelines Add Cosibelimab for Locally Advanced CSCC
4
Rusfertide Improves Hematocrit Control, Reduces Phlebotomy in Polycythemia Vera
5